FAYUVI
- Product NDC
- 69794-313
- Requested package NDC
- 69794-313-30
- 11-digit product format
- 697940313
- Labeler code
- 69794
- Product ID
- 69794-313_453f2a2e-d064-41ba-a715-11285409d478
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rebisufligene etisparvovec-hopf
- Dosage form
- KIT
- Labeler
- Ultragenyx Pharmaceutical Inc.
- Application
- BLA125845
- Marketing category
- BLA
- Marketing start
- 2026-10-31
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- FAYUVI
- Listing expiration
- 2027-12-31
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2755669 | Internal RxNorm lookup |
| 2755676 | Internal RxNorm lookup |
| 2755678 | Internal RxNorm lookup |
| 2755679 | Internal RxNorm lookup |
| 2755680 | Internal RxNorm lookup |
| 2755681 | Internal RxNorm lookup |
| 2755684 | Internal RxNorm lookup |
| 2755685 | Internal RxNorm lookup |
| 2755686 | Internal RxNorm lookup |
| 2755687 | Internal RxNorm lookup |
| 2755688 | Internal RxNorm lookup |
| 2755689 | Internal RxNorm lookup |
| 2755701 | Internal RxNorm lookup |
| 2755702 | Internal RxNorm lookup |
| 2755703 | Internal RxNorm lookup |
| 2755704 | Internal RxNorm lookup |
| 2755705 | Internal RxNorm lookup |
| 2755706 | Internal RxNorm lookup |
| 2755707 | Internal RxNorm lookup |
| 2755708 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 996fc33a-26d3-4fae-bd0c-a2edd7764539 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FAYUVI | REBISUFLIGENE ETISPARVOVEC-HOPF | Ultragenyx Pharmaceutical Inc. | 996fc33a-26d3-4fae-bd0c-a2edd7764539 | 2026-10-01 | Warnings, Adverse reactions | BLA125845 69794-313-30 69794-313 69794031330 |
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125845 | Fayuvi | rebisufligene etisparvovec-hopf | 351(a) | Rx | 2026-10-01 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 69794-313-30 | 69794031330 | 1 KIT in 1 CARTON (69794-313-30) * 2 mL in 1 VIAL (69794-300-01) | 1 kit | 2026-10-31 | No | No | Current |